States Set Different COVID-19 Vaccination Priorities for People with High-Risk Conditions February 16, 2021 News Release People with medical conditions that put them at higher risk of developing serious COVID-19 illness are next in line to get vaccinated in many states, though states are making very different choices about how to prioritize those within this large group, finds a KFF analysis of state policies. The U.S.…
Attitudes Towards COVID-19 Vaccination Among Black Women And Men February 19, 2021 Poll Finding This analysis examines Black adults’ attitudes, concerns, and intentions regarding a COVID-19 vaccine. While Black men and women are similar in many of their views, there is a gender gap in some COVID-19 vaccine attitudes and intentions.
Where Do Americans Get Vaccines and How Much Does It Cost to Administer Them? February 16, 2021 Issue Brief A new issue brief shows where Americans typically get flu vaccines in the U.S. and how much it costs to administer flu and other vaccines. Among the analysis’ findings: while most people get flu vaccines at a doctor’s office or retail health clinic, White people are more likely than Black,…
Daily COVID-19 Vaccinations Could Nearly Double by the End of March if Supply Keeps Up February 17, 2021 Blog This policy watch looks at the expected ramp up in vaccine supply, and what this could mean for increasing the number of people getting vaccinated.
The Next Phase of Vaccine Distribution: High-Risk Medical Conditions February 16, 2021 Blog This Policy Watch examines how the 50 states and DC are defining “high-risk medical conditions” for COVID-19 vaccine prioritization, including whether they follow CDC’s recommendations or deviate in some way.
This Week in Coronavirus: February 5 to February 11 February 12, 2021 Blog During the 55th week since the first coronavirus case appeared in the United States, the world is at nearly 108 million COVID-19 cases. The U.S. approached 27.4 million cases and a total of 475,400 deaths.
Reasons Vary Why People Want to “Wait and See” Before Getting a COVID-19 Vaccine. February 12, 2021 News Release Nearly a third (31%) of the public says they want to “wait and see” how a COVID-19 vaccine works for others before they would get it, representing a critical group for efforts aimed at boosting vaccinations. The latest analysis from the KFF COVID-19 Vaccine Monitor highlights how attitudes differ by…
KFF COVID-19 Vaccine Monitor: What Do We Know About Those Who Want to “Wait and See” Before Getting a COVID-19 Vaccine? February 12, 2021 Poll Finding Thirty-one percent of the public wants to “wait and see” how the COVID-19 vaccine is working for other people before getting vaccinated themselves. While they share a similar level of vaccine hesitancy, this group is not monolithic in their attitudes and beliefs. This brief examines how people with different partisan identities and those belonging to different racial and ethnic groups differ in their levels of concern about the vaccine and may respond differently to messages and information.
People of Color Especially Don’t Know Where or When to Get a COVID-19 Vaccine February 10, 2021 Slide In the January report from the COVID-19 Vaccine Monitor, the lack of information around where and when to get the COVID-19 vaccine is particularly pronounced among Hispanic and Black adults compared to White Adults. Learn more in this Chart of the Week.
In Their Own Words: What People are Saying about Getting a COVID-19 Vaccine February 8, 2021 News Release As the country broadens COVID-19 vaccine distribution efforts, the latest research from the KFF COVID-19 Vaccine Monitor finds that side effects, including allergic reactions and long-term consequences, are the public’s top concern about getting vaccinated when asked to describe what worries them in their own words. The latest report from…
